A Genetic Risk Score for Thyroid Peroxidase Antibodies Associates With Clinical Thyroid Disease in Community-Based Populations
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
CONTEXT: Antibodies against thyroid peroxidase (TPOAbs) are detected in 90% of all patients with Hashimoto thyroiditis, the most common cause of hypothyroidism. Hypothyroidism is associated with a range of adverse outcomes. The current knowledge of its genetic underpinnings is limited. OBJECTIVE: The purpose of this study was to identify novel genetic variants associated with TPOAb concentrations and positivity using genome-wide association data and to characterize their association with thyroid function and disease. DESIGN, SETTING, AND PARTICIPANTS: We studied European ancestry participants of 3 independent prospective population-based studies: Atherosclerosis Risk In Communities study (n = 7524), Study of Health in Pomerania (n = 3803), and Study of Health in Pomerania-TREND (n = 887). EXPOSURE: Single nucleotide polymorphisms (SNPs), individually and combined into a genetic risk score (GRS), were examined. MAIN OUTCOMES: The main outcomes were TPOAb concentrations and positivity, thyroid hormone concentrations (TSH, free T4), and clinical thyroid diseases (subclinical and overt hypothyroidism and goiter). RESULTS: Significantly associated single nucleotide polymorphisms (P < 5 · 10(-8)) mapped into 4 genomic regions not previously implicated for TPOAbs (RERE, extended HLA region) and into 5 previously described loci. A higher Genetic Risk Score (GRS) based on these 9 SNPs showed strong and graded associations with higher TPOAb, TSH, and lower free T4 concentrations (P < .001). Compared with individuals in the lowest GRS quartile, those in the highest quartile had 1.80-fold higher odds of subclinical hypothyroidism (95% confidence interval, 1.27-2.55) and 1.89-fold higher odds of overt hypothyroidism (95% confidence interval, 1.24-2.87). CONCLUSION: The identification of 4 novel genetic loci associated with TPOAb concentrations and positivity gives further insight into the genetic underpinnings of hypothyroidism. A GRS showed strong and graded associations with markers of thyroid function and disease in independent population-based studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The current polygenic risk scores focusing on thyroid function 45,49 are too limited by their discriminatory power to be used in clinical practice.”
From Hypothyroidism (2024) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a follow-up study, these variants were, together with others, combined in a polygenic risk score, which was shown to be associated with the risk of developing both subclinical and overt hypothyroidism.49”
From Hypothyroidism (2024) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In this study, compared with individuals in the lowest quartile for genetic risk score, those in the highest quartile had a higher odds of subclinical hypothyroidism (odds ratio [OR] 1•80; 95% CI 1•27-2•55) and a higher odds of overt hypothyroidism (1•89; 1•24-2•87).49”
From Hypothyroidism (2024) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
(1989) · PubMed · Cited by 3,139
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Systematic identification of trans eQTLs as putative drivers of known disease associations
Westra, H.-J., Peters, M. J., Esko, T., Yaghootkar, H., Schurmann, C., Kettunen, J., Christiansen, M. W., Fairfax, B. P., Schramm, K., Powell, J. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2756 · Cited by 1,658
Self-citationGarber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Cohort Profile: The Study of Health in Pomerania
Volzke, H., Alte, D., Schmidt, C. O., Radke, D., Lorbeer, R., Friedrich, N., Aumann, N., Lau, K., Piontek, M., Born, G., et al. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyp394 · Cited by 1,000
Research works printed but not linked: 4
- [7]7. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348:2646–2655. [DOI] [PubMed] [Google Scholar]
- [20]20. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. Volumetric analysis of thyroid lobes by real-time ultrasound (author's transl). Dtsch Med Wochenschr. 1981;106:1338–1340. [DOI] [PubMed] [Google Scholar]
- [21]21. Gutekunst R, Becker W, Hehrmann R, Olbricht T, Pfannenstiel P. Ultrasonic diagnosis of the thyroid gland [in German]. Dtsch Med Wochenschr. 1988;113:1109–1112. [DOI] [PubMed] [Google Scholar]
- [38]38. Mikos H, Mikos M, Obara-Moszynska M, Niedziela M. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol. 2014;65:150–155. [DOI] [PubMed] [Google Scholar]
Cited by
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
“Genome wide association data have identified regions associated with TPO antibody positivity 159 and thyroid disease 159 .”
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Self-citationThe Rotterdam Study: 2018 update on objectives, design and main results
Ikram, M. A., Brusselle, G. G. O., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., Stricker, B. H., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0321-4 · Cited by 434
“strong and graded associations with markers of thyroid function and disease in independent population-based studies [194].”
BackgroundThe Rotterdam Study: 2016 objectives and design update
Hofman, A., Brusselle, G. G. O., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Ikram, M. A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0082-x · Cited by 382
“A Genetic Risk Score showed strong and graded associations with markers of thyroid function and disease in independent populationbased studies [218].”
BackgroundTaylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
“49 In this study, compared with individuals in the lowest quartile for genetic risk score, those in the highest quartile had a higher odds of subclinical hypothyroidism (odds ratio [OR] 1·80; 95% CI 1·27 – 2·55) and a higher odds of overt hypothyroidism (1·89; 1·24 –2 ·87).”
Cappola, A. R., Desai, A. S., Medici, M., Cooper, L. S., Egan, D., Sopko, G. S., Fishman, G. I., Goldman, S., Cooper, D. S., Mora, S., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036859 · Cited by 169
Ellervik, C., Roselli, C., Christophersen, I. E., Alonso, A., Pietzner, M., Sitlani, C. M., Trompet, S., Arking, D. E., Geelhoed, B., Guo, X., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2018.4635 · Cited by 108
The emerging role of exosomes in innate immunity, diagnosis and therapy
Gangadaran, P., Madhyastha, H., Madhyastha, R., Rajendran, R. L., Nakajima, Y., Watanabe, N., Velikkakath, A. K. G., Hong, C. M., Gopi, R. V., Muthukaliannan, G. K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1085057 · Cited by 111
“Recent studies have reported that the crucial role of apoptosis in the maintenance of tissue homeostasis and the pathogenesis of immune diseases and AITDs were known for dysregulation of apoptotic signaling pathways (58).”
BackgroundInfluentialCappola, A. R., Desai, A. S., Medici, M., Cooper, L. S., Egan, D., Sopko, G., Fishman, G. I., Goldman, S., Cooper, D. S., Mora, S., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0416 · Cited by 94
Martin, S. S., Daya, N., Lutsey, P. L., Matsushita, K., Fretz, A., McEvoy, J. W., Blumenthal, R. S., Coresh, J., Greenland, P., Kottgen, A., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00986 · Cited by 63
“3310 Martin et al Thyroid Function, CV Risk Factors, and Incident CVD J Clin Endocrinol Metab, September 2017, 102(9):3306–3315”
BackgroundMethodInfluentialGodlewska, M., & Banga, P. J. (2019) · Biochimie · doi:10.1016/j.biochi.2019.02.003 · Cited by 60
Schultheiß, U. T., Daya, N. R., Grams, M. E., Seufert, J., Steffes, M. W., Coresh, J., Selvin, E., & Köttgen, A. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw301 · Cited by 63
“5th percentiles for thyroid hormone measurements [18].”
Wang, J., Zhuang, Z., Shao, C., Yu, C., Wang, W., Zhang, K., Meng, X., Gao, J. L., Tian, J., Zheng, J., et al. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001505 · Cited by 60
“As presented in Table 1, the clinical measures of thyroid function include FT4 and TSH levels within the reference range, concentration of TPOAb, and FT3:FT4 ratio from the Atrial Fibrillation Consortium (AFGen 2018 GWAS dataset, n= 537,409 European-descent individuals).([5,13-20])”
BackgroundGeorge, K. M., Lutsey, P. L., Selvin, E., Palta, P., Windham, B. G., & Folsom, A. R. (2019) · Journal of Endocrinology and Metabolism · doi:10.14740/jem588 · Cited by 54
“Five clinical categories (subclinical hypothyroidism, subclinical hyperthyroidism, overt hypothyroidism, overt hyperthyroidism and euthyroidism) were used to define thyroid dysfunction based on ARIC-derived cut-points associated with thyroid-related genes and genetic risk score (Table 1) [7, 28].”
MethodHypothyroidism and Kidney Function: A Mendelian Randomization Study
Ellervik, C., Mora, S., Ridker, P. M., & Chasman, D. I. (2020) · Thyroid · doi:10.1089/thy.2019.0167 · Cited by 55
“Thyroid function: Independent SNPs with minor allele frequency >1% have been identified in GWASs ( p < 5 · 10) among Europeans for TSH (N SNPs = 42) and fT4 (N = 21) concentrations in the reference range (42–44), TPOAb concentration (N = 5) (45,46), and hypothyroidism (N = 30) (39– 41) (Supplementary Data).”
BackgroundMethodEpidemiology, Types, Causes, Clinical Presentation, Diagnosis, and Treatment of Hypothyroidism
Zamwar, U. M., & Muneshwar, K. N. (2023) · Cureus · doi:10.7759/cureus.46241 · Cited by 116
“An increased genetic risk score, which was calculated using five genetic variants for thyroid peroxidase antibodies that were found by the genome-wide association studies, has shown a graded relationship between increased levels of TSH and clinical hypothyroidism [25,26].”
BackgroundThe Genetic Basis of Thyroid Function: Novel Findings and New Approaches
Kuś, A., Chaker, L., Teumer, A., Peeters, R. P., & Medici, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz225 · Cited by 44
“In another study, Schultheiss et al (101) showed that a GRS based on nine variants associated with thyroid peroxidase antibodies (TPOAbs) in a dedicated GWAS (90) can be used to identify individuals with an increased risk of both overt and subclinical hypothyroidism (interquartile odds ratio of 1.”
BackgroundSelf-citationEllervik, C., Mora, S., Kuś, A., Åsvold, B. O., Marouli, E., Deloukas, P., Sterenborg, R. B. T. M., Teumer, A., Burgess, S., Sabater‐Lleal, M., et al. (2021) · Thyroid · doi:10.1089/thy.2021.0055 · Cited by 39
“For TPOAb, we used two European ancestry studies by Schultheiss et al. (20) S1).”
Medici, M., Visser, T. J., & Peeters, R. P. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.04.002 · Cited by 39
Thyroid Peroxidase Revisited – Whatʼs New?
Godlewska, M., Gaweł, D., Buckle, A. M., & Banga, J. P. (2019) · Hormone and Metabolic Research · doi:10.1055/a-1057-9469 · Cited by 35
“[23] Schultheiss UT, Teumer A, Medici M et al.”
BackgroundKnutsen, K. V., Madar, A. A., Brekke, M., Meyer, H. E., Eggemoen, Å. R., Mdala, I., & Lagerløv, P. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00037 · Cited by 26
The antigenic link between thyroid autoimmunity and breast cancer
Muller, I., & Barrett-Lee, P. J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.013 · Cited by 26
Brčić, L., Barić, A., Gračan, S., Torlak, V., Brekalo, M., Škrabić, V., Zemunik, T., Barbalić, M., Punda, A., & Perica, V. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-41850-6 · Cited by 23
Khoshi, A., Sirghani, A., Ghazisaeedi, M., Mahmudabadi, A. Z., & Azimian, A. (2017) · Hormones · doi:10.14310/horm.2002.1721 · Cited by 17
Chen, G., Lv, H., Zhang, X., Gao, Y., Liu, X., Gu, C., Xue, R., Wang, Q., Chen, M., Zhai, J., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.101 · Cited by 18
Brandt, J., Borgquist, S., Almgren, P., Försti, A., Huss, L., Melander, O., & Manjer, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.31156 · Cited by 16
“Rs301806 is located near RERE gene in the distal region of chromosome 1.(22,45) Structural rearrangements in this genomic region have been linked to several malignancies, including neuroblastoma and colorectal cancer, and the region is thought to contain tumor suppressor genes.”
BackgroundMatana, A., Popović, M., Boutin, T., Torlak, V., Brdar, D., Gunjača, I., Kolčić, I., Perica, V. B., Punda, A., Polašek, O., et al. (2018) · Genomics · doi:10.1016/j.ygeno.2018.04.012 · Cited by 19
Li, H., Li, M., Dong, S., Zhang, S., Dong, A., & Zhang, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1126339 · Cited by 15
“conducted two GWAS studies that identified a total of five susceptibility loci associated with TPOAB that predicted which TPOAB positivity predisposed to the development of clinical thyroid dysfunction (29, 30).”
BackgroundAhmed, H. S., Nsr-Allah, A. A.-E. M., El-Fatah, A. H. A., Mahmoud, A. A., & Fikry, A. A. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200715101907 · Cited by 12
Influence of Rapid Urbanization on Thyroid Autoimmune Disease in China
Chen, Y., Han, B., Yu, J., Chen, Y., Cheng, J., Zhu, C., Xia, F., Wang, N., & Lu, Y. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9967712 · Cited by 11
“Four novel genetic loci (rs301799 near RERE, rs3094228, rs1894407, and rs9277555 in the HLA region) were identified as being associated with TPOAb concentrations [19].”
BackgroundWang, J., Zhuang, Z., Yu, C., Wang, W., Wang, W.-X., Zhang, K., Meng, X., Gao, J. L., Tian, J., Zheng, J., et al. (2022) · PubMed Central · doi:10.11909/j.issn.1671-5411.2022.01.004 · Cited by 13
“The r(2) thresholds and p values of the IVs are reported in Table 1 and eTable 1.([15,16])”
BackgroundMatana, A., Boutin, T., Torlak, V., Brdar, D., Gunjača, I., Kolčić, I., Perica, V. B., Punda, A., Polašek, O., Barbalić, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz239 · Cited by 8
Bidirectional Mendelian Randomization Analysis for Vitamin D and Thyroid Peroxidase Antibody
Chen, Y., Han, B., Zhu, C., Li, Q., Chen, C., Zhai, H., Wang, N., Chen, Y., & Lu, Y. (2022) · International Journal of Endocrinology · doi:10.1155/2022/2260388 · Cited by 7
“All SNPs used in this study have previously been shown to be significantly associated with vitamin D or TPOAb concentration in large meta-analysis of GWAS [29, 30].”
MethodInfluentialChen, Y., Zhang, Z., Chen, Y., Liu, P., Yi, S., Fan, C., Zhao, W., & Liu, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.202 · Cited by 6
Liu, X., Wu, J., Jiang, L., Xu, Y., & Liu, B. (2021) · Clinical Endocrinology · doi:10.1111/cen.14580 · Cited by 5
“Positive TPO‐Ab was defined as a serum TPO‐Ab > 34 IU/ml, based on assay manufacturer guidelines.(10)”
MethodHan, B., Chen, C., Chen, Y., Wang, N., Yu, J., Cheng, J., Chen, Y., Zhu, C., & Lu, Y. (2020) · European Thyroid Journal · doi:10.1159/000506701 · Cited by 4
Thyroid Disorder Management in Developing Countries
Mallhi, T. H., Kanwal, H., Umm‐e‐Kalsoom, Mushtaq, S., Akash, M. S. H., Ahmad, N., Khan, Y. H., Butt, M. H., Khan, T. M., & Khan, A. (2023) · Springer eBooks · doi:10.1007/978-3-030-74786-2_13-1 · Cited by 6
Shirizadeh, A., Borzouei, S., Razavi, Z., Taherkhani, A., Faradmal, J., & Solgi, G. (2024) · Immunogenetics · doi:10.1007/s00251-024-01339-7 · Cited by 4
“While clinical, demographic, and other contributory factors can be used for GRS calculation, it is typically evaluated based on genetic variants (Schultheiss et al. 2015; Qu et al. 2021).”
Jiang, Y.-J., Xiong, Y., Huang, T., & Xiao, Y.-X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1378969 · Cited by 6
Adam, L. N., & Abbas, A. M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11174-y · Cited by 4
“Similarly, a genetic risk score (GRS) comprising multiple TPO-related loci was shown in several European cohorts to robustly correlate with higher TPO-antibody levels, elevated TSH, and increased odds of subclinical or overt hypothyroidism [ 68].”
Dementia and Mild Cognitive Impairment: Epidemiologic Research of Risk Factors
George, K. M. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Thyroid Genetics and the Cardiovascular System
Kuś, A., Teumer, A., Chaker, L., & Medici, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_15
Asif, M., Masood-uz-Zaman, Hamza, A., & Haq, A. (2022) · The Professional Medical Journal · doi:10.29309/tpmj/2022.29.06.6812
Shirizadeh, A., Borzouei, S., Razavi, Z., Taherkhani, A., Faradmal, J., & Solgi, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3558098/v1
Cheng, J., Lin, Y., Chen, Y., Han, B., Wang, N., Li, Q., & Lu, Y. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.06.014
P300 event-related potential in children with hypothyroidism
Ravi, N., Bharshankar, R. N., Hulke, S., Thakare, A. E., Wakode, S. L., Krishna, N. S., John, N., Taranikanti, M., Kalpana, M., Prafull, K., et al. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_297_25
“[7] Apart from these, a number of drugs have been implicated in the causation of iatrogenic hypothyroidism; these include interferon’s and monoclonal antibodies, [8] amiodarone, [9] lithium, [10] administration of radiographic contrast agents.”
Thyroid hormones are associated with pituitary and thyroid volume in a population-based study
Weihs, A. L., Wittfeld, K., Bülow, R., Wielpütz, M. O., Nauck, M. A., Völzke, H., Grabe, H. J., & Teumer, A. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag060
“…TSH in SHIP-TREND-0 has previously [24] been established as [0.49; 3.29] mU/L. Serum autoantibodies to thyroperoxidase were measured by an enzyme immunoassay (VARELISA, Elias Medizintechnik GmbH, Freiburg, Germany; Roche Cat# 06368590190, RRID:AB_2916057) using the cutoffs as described before [25].”
InfluentialSadrinasab, S., Jeddi, S., Azizi, F., & Ghasemi, A. (2026) · Intern J Endocrinol Metab · doi:10.5812/ijem-167774
Zhu, R.-C., Liu, L., Wen, J., Wei, X., Chu, C., Hu, J., Lu, Y., & Feng, Y. (2026) · Clinical Rheumatology · doi:10.1007/s10067-026-08187-8
“Summary statistics for TPOAb were obtained from Wei et al.[13] and Schultheiss et al.[14], while RA-related data were derived from Ishigaki et al.[15] and the FinnGen consortium [16] (Fig.”
InfluentialMaternal Thyroid Dysfunction During Pregnancy and Childhood Autism or Other Developmental Outcomes
Kaplan, Z. B., Pearce, E. N., Miller, M., Tancredi, D. J., Hertz‐Picciotto, I., Shin, H., & Schmidt, R. J. (2026) · Autism Research · doi:10.1002/aur.70346
Metadata
- Authors
- Schultheiss, U. T., Teumer, A., Medici, M., Li, Y., Daya, N., Chaker, L., Homuth, G., Uitterlinden, A. G., Nauck, M., Hofman, A., Selvin, E., Völzke, H., Peeters, R. P., & Köttgen, A.
- Affiliations
- University of Freiburg (DE)
- Universitätsmedizin Greifswald (DE)
- Erasmus MC (NL)
- Johns Hopkins University (US)
- Universität Greifswald (DE)
- Corresponding author
- Köttgen, Anna
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-05
- Volume
- 100
- Issue
- 5
- Pages
- E799-E807
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4422885
- OpenAlex
- W2163183762
- Cited by
- 50
- References
- 53
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 10 · 2018: 2 · 2017: 7 · 2016: 1 · 2015: 1
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Funders
- U.S. Public Health Service (HHSN268201100012C), HSN268201100006C, HHSN2682 01100010C, HHSN268201100007 C, HHSN2682011-00008C, HHSN 268200625226C, HHSN2682‐01100011C, HSN268201100009C, HHSN 268201100005C)
- National Heart, Lung, and Blood Institute (HHSN268201 100012C, HHSN268201100007I, HHSN268201100007C, HHSN2682 01100008C, HHSN268201100011C, HHSN2682011-00005I, R01 HL-59367, HHSN268201100005C, HHSN268201100005G, HHSN268201100010C, HHSN268201100011I, R01HL087641, R01HL059367, HHSN2682011-00008I, R01HL086694)
- National Human Genome Research Institute (U01HG004402)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK089174)
- National Center for Research Resources (UL1RR025005)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid peroxidase antibodies, polygenic risk score, hypothyroidism, subclinical hypothyroidism, overt hypothyroidism, goiter, thyroid function, single nucleotide polymorphisms, RERE, HLA region, Hashimoto's thyroiditis, genetic susceptibility
- MeSH terms
- Female, Humans, Iodide Peroxidase, Male, Middle Aged, Prospective Studies, Risk Factors, Thyroid Diseases, Thyrotropin, Thyroxine, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.